LyoHUB Co-Director, Dr. Elizabeth Topp leads effort to develop a new drug form may help treat osteoporosis, calcium-related disorders

Purdue University innovators developed a stabilized form of human calcitonin, which is a peptide drug already used for people with osteoporosis. Researchers at Purdue created a prodrug form of the peptide hormone to increase its effectiveness as an osteoporosis treatment. To read the full article, visit New drug form may help treat osteoporosis, calcium-related disorders - Purdue University News